CLINICAL ROLE -
Cigna and Express Scripts Announce Acquisition Agreement
Cigna Corporation and Express Scripts have announced an agreement in which Cigna will purchase the pharmacy benefit manager (PBM) for $67 billion, which includes $15 billion in Express Scripts debt.
Read More
Cigna to Acquire Express Scripts
Cigna to acquire major pharmacy benefit manager for $67 billion.
National Institutes of Health Grants $7.7 Million for HIV Research
New research may overcome hurdles to eliminating viral reservoirs that prevent curing HIV.
Inflammatory Bowel Disease May Elevate Cardiovascular Disease Risk
Patients between 18 and 24 years of age with IBD may have a greater risk of heart attacks.
Experimental Approach Could Treat Deadly Nerve Tumors
Malignant peripheral nerve sheath tumors are currently incurable.
Generic Hepatitis C Drugs Begin to Emerge
First Abbreviated New Drug Application filed for sofosbuvir (Sovaldi).
Inflammatory Bowel Disease Possibly Linked to Heart Attack Risk
Younger patients with IBD may be at a high risk of experiencing a heart attack.
Novel Infusion Options Approved for Opdivo
FDA approves shorter administration periods and new dosing options for nivolumab (Opdivo).
New Genetic Changes Associated with Pancreatic Cancer Risk
Research into gene variants may improve targeted treatments for pancreatic cancer.
FDA OKs Direct-to-Consumer Cancer Mutation Test
A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.
HIV Drug Combos Launched with Promise of Lower Costs
Mylan will reduce the wholesale acquisition costs of Smyfi Lo and Cimduo, which are both combination therapies for HIV.
Oxygen-Sensing Molecule May Lower Inflammation in Autoimmune Diseases
Targeting an energy-related molecule could prevent the onset of autoimmune diseases.
FDA Approves Direct-to-Consumer Cancer Mutation Test
Exosomes Could Help Track HIV Disease Progression
HIV packages a key viral protein in exosomes to transport throughout the body.
Molecular Therapy Sparks Remyelination, Hope for MS Cure
An enzyme blockade could assist remyelination in patients with peripheral nerve damage.
Stem Cell Therapy Could Reverse Multiple Sclerosis Disability
Stem cell treatments improved muscle strength and disability among patients with multiple sclerosis.
Trending News Today: Hemophilia Drug Costs Strain Medicaid
Top news of the day from across the health care landscape.
Trending News Today: Arkansas Medicaid Work Requirements Approved
Multiple Sclerosis Drug Pulled Due to Brain Inflammation Risks
Daclizumab (Zinbryta) may cause brain inflammation among patients with relapsing multiple sclerosis.
FDA Accepts sBLA of Dupilumab for Asthma
Biologic drug demonstrates efficacy in moderate-to-severe asthma.
Nut Consumption Could Lower Colon Cancer Recurrence
Patients with colon cancer who regularly consumed tree nuts had a 46% improvement in disease-free survival.
FDA Accepts Dupilumab sBLA for Treatment of Asthma
Sanofi recently announced that the FDA has accepted the supplemental Biologics License Application (sBLA) of dupilumab (Dupixent) for the maintenance treatment of asthma.
FDA Issues Warning Over Fraudulent Influenza Drugs
The FDA advises patients to be cautious when purchasing influenza drugs online.
Adding Immunotherapy to Neurofibromatosis Treatment May Mitigate Hearing Loss
Current treatments for neurofibromatosis tumors may result in drug resistance.
Trending News Today: States Struggle to Provide Drug Use Disorder Treatment
Trending News Today: Flu Season Peaked in Early February
FDA Warns of Fraudulent, Unapproved Influenza Drugs
Officials with the FDA have issued a statement warning Consumers to be wary of unapproved products that claim to prevent, treat, or cure influenza.
Cases of Rare Skin Cancer on the Rise
Increase in Merkel cell carcinoma cases outpaces the rate of melanoma.
Ovarian Cancer Screening Not Recommended
The US Preventive Services Task Force recommends against ovarian cancer screening.
Experimental ERK Inhibitor Demonstrates Potential as Melanoma Therapy
ERK inhibitors may increase the efficacy of other anti-cancer drugs.